Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine

Midkine (MK) is a cytokine that modulates amphetamine-induced striatal astrogliosis, suggesting a possible role of MK in neuroinflammation induced by amphetamine. To test this hypothesis, we studied astrogliosis and microglial response induced by amphetamine (10 mg/kg i.p. four times, every 2 h) in...

Full description

Saved in:
Bibliographic Details
Main Authors: Marta Vicente-Rodríguez, Rosalía Fernández-Calle, Esther Gramage, Carmen Pérez-García, María P. Ramos, Gonzalo Herradón
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2016/9894504
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551432578924544
author Marta Vicente-Rodríguez
Rosalía Fernández-Calle
Esther Gramage
Carmen Pérez-García
María P. Ramos
Gonzalo Herradón
author_facet Marta Vicente-Rodríguez
Rosalía Fernández-Calle
Esther Gramage
Carmen Pérez-García
María P. Ramos
Gonzalo Herradón
author_sort Marta Vicente-Rodríguez
collection DOAJ
description Midkine (MK) is a cytokine that modulates amphetamine-induced striatal astrogliosis, suggesting a possible role of MK in neuroinflammation induced by amphetamine. To test this hypothesis, we studied astrogliosis and microglial response induced by amphetamine (10 mg/kg i.p. four times, every 2 h) in different brain areas of MK−/− mice and wild type (WT) mice. We found that amphetamine-induced microgliosis and astrocytosis are enhanced in the striatum of MK−/− mice in a region-specific manner. Surprisingly, LPS-induced astrogliosis in the striatum was blocked in MK−/− mice. Since striatal neuroinflammation induced by amphetamine-type stimulants correlates with the cognitive deficits induced by these drugs, we also tested the long-term effects of periadolescent amphetamine treatment (3 mg/kg i.p. daily for 10 days) in a memory task in MK−/− and WT mice. Significant deficits in the Y-maze test were only observed in amphetamine-pretreated MK−/− mice. The data demonstrate for the first time that MK is a novel modulator of neuroinflammation depending on the inflammatory stimulus and the brain area considered. The data indicate that MK limits amphetamine-induced striatal neuroinflammation. In addition, our data demonstrate that periadolescent amphetamine treatment in mice results in transient disruption of learning and memory processes in absence of endogenous MK.
format Article
id doaj-art-e1c9a1f752e8441cbd51b4e1a171051b
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-e1c9a1f752e8441cbd51b4e1a171051b2025-02-03T06:01:33ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/98945049894504Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by MidkineMarta Vicente-Rodríguez0Rosalía Fernández-Calle1Esther Gramage2Carmen Pérez-García3María P. Ramos4Gonzalo Herradón5Pharmacology Lab, Department of Pharmaceutical and Health Sciences, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, SpainPharmacology Lab, Department of Pharmaceutical and Health Sciences, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, SpainPharmacology Lab, Department of Pharmaceutical and Health Sciences, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, SpainPharmacology Lab, Department of Pharmaceutical and Health Sciences, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, SpainBiochemistry and Molecular Biology Lab, Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, SpainPharmacology Lab, Department of Pharmaceutical and Health Sciences, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, SpainMidkine (MK) is a cytokine that modulates amphetamine-induced striatal astrogliosis, suggesting a possible role of MK in neuroinflammation induced by amphetamine. To test this hypothesis, we studied astrogliosis and microglial response induced by amphetamine (10 mg/kg i.p. four times, every 2 h) in different brain areas of MK−/− mice and wild type (WT) mice. We found that amphetamine-induced microgliosis and astrocytosis are enhanced in the striatum of MK−/− mice in a region-specific manner. Surprisingly, LPS-induced astrogliosis in the striatum was blocked in MK−/− mice. Since striatal neuroinflammation induced by amphetamine-type stimulants correlates with the cognitive deficits induced by these drugs, we also tested the long-term effects of periadolescent amphetamine treatment (3 mg/kg i.p. daily for 10 days) in a memory task in MK−/− and WT mice. Significant deficits in the Y-maze test were only observed in amphetamine-pretreated MK−/− mice. The data demonstrate for the first time that MK is a novel modulator of neuroinflammation depending on the inflammatory stimulus and the brain area considered. The data indicate that MK limits amphetamine-induced striatal neuroinflammation. In addition, our data demonstrate that periadolescent amphetamine treatment in mice results in transient disruption of learning and memory processes in absence of endogenous MK.http://dx.doi.org/10.1155/2016/9894504
spellingShingle Marta Vicente-Rodríguez
Rosalía Fernández-Calle
Esther Gramage
Carmen Pérez-García
María P. Ramos
Gonzalo Herradón
Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine
Mediators of Inflammation
title Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine
title_full Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine
title_fullStr Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine
title_full_unstemmed Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine
title_short Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine
title_sort midkine is a novel regulator of amphetamine induced striatal gliosis and cognitive impairment evidence for a stimulus dependent regulation of neuroinflammation by midkine
url http://dx.doi.org/10.1155/2016/9894504
work_keys_str_mv AT martavicenterodriguez midkineisanovelregulatorofamphetamineinducedstriatalgliosisandcognitiveimpairmentevidenceforastimulusdependentregulationofneuroinflammationbymidkine
AT rosaliafernandezcalle midkineisanovelregulatorofamphetamineinducedstriatalgliosisandcognitiveimpairmentevidenceforastimulusdependentregulationofneuroinflammationbymidkine
AT esthergramage midkineisanovelregulatorofamphetamineinducedstriatalgliosisandcognitiveimpairmentevidenceforastimulusdependentregulationofneuroinflammationbymidkine
AT carmenperezgarcia midkineisanovelregulatorofamphetamineinducedstriatalgliosisandcognitiveimpairmentevidenceforastimulusdependentregulationofneuroinflammationbymidkine
AT mariapramos midkineisanovelregulatorofamphetamineinducedstriatalgliosisandcognitiveimpairmentevidenceforastimulusdependentregulationofneuroinflammationbymidkine
AT gonzaloherradon midkineisanovelregulatorofamphetamineinducedstriatalgliosisandcognitiveimpairmentevidenceforastimulusdependentregulationofneuroinflammationbymidkine